BWX Technologies’ Kinectrics Deal Under Probe
The Competition Bureau has obtained court orders to gather information to advance its investigation into BWX Technologies’ proposed acquisition of Kinectrics. BWX Technologies and Kinectrics operate in the nuclear medicine sector, among other nuclear sectors.
BWX Technologies and Kinectrics, directly or through a joint venture or partnership, provide products and services at various stages of the medical isotope value chain.
The Bureau is investigating whether the acquisition is likely to result in a substantial lessening or prevention of competition in Canada’s nuclear medicine sector. The acquisition includes Kinectrics’ interest in Isogen, a company that enables the production of medical isotopes and is jointly owned with Framatome Canada.
The court orders, granted by the Federal Court of Canada, require three market participants in the nuclear medicine sector to provide information and produce records and data related to but not limited to transaction agreements, capacity, sales, and competitive dynamics. The entities receiving court orders are Bruce Power, Ontario Power Generation (OPG) and Framatome Canada.
The Bureau also issued supplementary information requests to BWX Technologies and Kinectrics.
BWX Technologies announced its plan to acquire Kinectrics on January 7, 2025.
https://www.canada.ca/en/competition-bureau/news/2025/04/competition-bureau-advances-an-investigation-into-bwx-technologies-proposed-acquisition-of-kinectrics.html